RxDoctor Payments Data

Beatrice St Claire, MD

Psychiatry · Modesto, CANPI 1518041144

Payments from drug & device makers

$2,161in general payments, 2019–2025

Across 107 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$513
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$323
  • Otsuka America Pharmaceutical, Inc.$276
  • Johnson & Johnson$254
  • Neurocrine Biosciences, Inc.$214
  • Teva Pharmaceuticals USA, Inc.$184
  • plus $398 from 6 others

What the payments were for

  • Food & beverage$2,11298%
  • Education$492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,161 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$7,346
Medicare patients
17
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole16$42,321
Invega SustennaPaliperidone Palmitate13$38,854
VraylarCariprazine Hcl24$33,631
Clozapine OdtClozapine24$13,624
Aripiprazole54$6,171
Fluphenazine Hcl20$3,855
Clozapine69$2,873
Haloperidol Decanoate56$1,932
Desvenlafaxine Succinate ErDesvenlafaxine Succinate25$1,814
Divalproex Sodium ErDivalproex Sodium44$1,092
Benztropine Mesylate76$951
Mirtazapine38$598
Haloperidol27$570
Duloxetine Hcl26$493
Olanzapine30$452

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$276$42,32116 claims
Johnson & JohnsonInvega Sustenna$254$38,85413 claims
AbbVieVraylar$170$33,63124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Modesto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →